Navigation Links
Novel Apolipoprotein A-I Therapy, CSL112, May Represent New Option for Reducing Recurrent Heart Attack Risk, Early CSL Studies Show
Date:11/5/2012

nd time-dependent manner and were maintained for at least 72 hours after infusion of CSL112 at 40 mg/kg and higher. Notable biomarker changes included elevations in PreBeta1-HDL (maximum=3,600%) and global cholesterol efflux capacity from macrophages (maximum=270%).  

In another study presented at the meeting, CSL112 was observed to have strong anti-inflammatory properties in human blood ex vivo. This property of CSL112 may prove to be beneficial in the reduction of inflammation associated with cardiovascular events.

"We are very encouraged by the early experience with CSL112 in the clinic and are looking forward to completing the mid-stage studies that are now in progress or being planned to start next year," said Chuck Shear, CSL Senior Director and Therapeutic Area Head.

About CSL112
CSL112 is a novel formulation of apolipoprotein A-I (ApoA-I), the chief component of high-density lipoprotein (HDL). It is purified from plasma and reconstituted to form HDL suitable for intravenous infusion. As demonstrated in pre-clinical and Phase 1 studies, CSL112 elevates cholesterol efflux capacity, as well as additional steps in reverse cholesterol transport. CSL112 demonstrates strong anti-inflammatory activity, as well.

About CSL
Headquartered in Melbourne, Australia, CSL Limited is a global biopharmaceutical company that develops, manufactures and markets biotherapies to prevent and treat rare and serious human diseases. CSL owns major facilities in Australia, Germany, Switzerland and the United States, and employs over 11,000 people in more than 25 countries. Visit www.csl.com.au for more information.

Contact

Sheila A. Burke
Director, Communications & Public Relations
Worldwide Commercial Operations
CSL Limited
C: 484-919-2618 (US)
Sheila.Burke at cslbehring.com

Eliot Harrison
MCS Healthcare Public Relations
C: 908-884-5252

SOURCE CSL Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics Closes $2 Million Private Placement
2. RayBiotech, Inc. and Abeome Corporation Announce an Agreement Related to Novel Research Products for Ovarian Cancer
3. Global eClinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies: MarketResearchReports.Biz
4. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
5. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
6. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic for Chinese Market
9. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
10. Strategic Agreement Launches Novel Drug Development Model
11. Kalidex Introduces Novel Fluoroquinolone, KPI-10, at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 2014  Varian Medical Systems (NYSE: VAR ... the fourth quarter of fiscal year 2014 following the ... The news release will be followed by a teleconference ... The news release and a link to the conference ... at: www.varian.com/investor .  To access the teleconference call ...
(Date:10/1/2014)... 2014   Royal Philips (NYSE: ... eCareCoordinator and eCareCompanion telehealth applications have received 510(k) ... (FDA). A part of Philips Hospital to Home,s ... eCareCompanion are focused on patient care within the ... be available through the cloud-based digital health platform, ...
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
Breaking Medicine Technology:Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 2Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 3Philips Secures 510(k) Clearance to Market the First Clinical Applications for its new Digital Health Platform 4Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3
... ViroPharma Incorporated (Nasdaq: VPHM ) today announced ... will present at the Stifel Nicolaus 2011 Healthcare Conference at ... is being held in Boston. ViroPharma,s presentations will ... available for a period of 14 days following the conferences. ...
... As the Joint Select Committee on Deficit Reduction examines options ... ten years, the Pharmaceutical Care Management Association (PCMA) ... to leverage greater use of pharmacy benefit management tools to ... that same time period. "Everyone in the pharmacy ...
Cached Medicine Technology:PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 2PCMA Outlines $100 Billion in Prescription Drug Savings for Deficit Reduction Committee 3
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining ... , Senior citizens can purchase a joint life insurance ... A joint policy is cheaper, but will only pay ... Life insurance can be used to cover important funeral ... online, as the application process is simple and straightforward. ...
(Date:10/1/2014)... 2014 Lifeinsurance-policy.com has released a ... life insurance prices for smokers. , Smoking will always ... Comparing quotes is the best method to find affordable ... customers who need coverage. , Whole life insurance ... the policy. Since the coverage is permanent, the initial ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 ... networking and relationship-marketing firm, announced today the ... Executive® and Project of the Year Awards ... makers representing organizations in financial services, commercial, ... large-scale technology endeavors that address key issues ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... Innovations announces the upcoming airing of Innovations with ... 20, 2014 at 7:30 a.m. EST/PT via Discovery Channel. ... scenes to learn about Break the Cycle’s comprehensive dating ... help and information Break the Cycle provides to teens ... abuse, how to navigate the legal system, and provides ...
Breaking Medicine News(10 mins):Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Affordable Whole Life Insurance Premiums for Smokers! 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2
... has been proposed as a key clinical problem ... The production of reactive oxygen species (ROS), including ... demonstrated in reperfusion injury. Resveratrol has been reported ... potent antioxidative effect via prevention of lipid peroxidation. ...
... favorite ritual might ease a friend or family member,s stay, , , ... friend is in the hospital over the holidays, you can help ... , "Being in the hospital, away from family and festivities, ... Foose, a chaplain at The Methodist Hospital in Houston, said in ...
... possible to grow human blood platelets in the laboratory ... Ohio State University Medical Center. , The findings, published ... Experimental Hematology , might one day enable blood ... can ease the chronically tight supply of these critical ...
... Birthday Victory Celebration at J Lounge in downtown Los Angeles, on Friday, ... to benefit the Blue Diamond Foundation, which was founded to assist people ... ... December 23, 2008 -- Boxer Manny Pacquiao, fresh off his victory against ...
... ingredients not listed on label , , MONDAY, Dec. 22 ... warned consumers Monday to avoid more than two dozen ... ingredients that could pose serious health risks. , The ... the Internet and some claim to contain only "natural" ...
... around the world communicate and do business. Thanks to advances ... same thing for medicine. , In ... prototype cell phone has been constructed that is capable of ... as testing water quality in undeveloped areas or disaster sites. ...
Cached Medicine News:Health News:Take the Holiday to the Hospital 2Health News:Bioreactors might solve blood-platelet supply problems 2Health News:Pacquiao Hosts Post-Christmas/Post-Birthday Victory Celebration 2Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Cell phones using lens-free imaging promise to improve health monitoring 2
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... Fast-Cath, Maximum, Maximum Xtra, and ... line of standard and specialty hemostasis ... recognized as the premier hemostasis introducers ... electrophysiology procedures including angiography, angioplasty, stenting, ...
... to close arteriotomies with ease and ... a simple trigger actvated mechanism, requires ... sheath gently locks onto the target ... site before, during, and after the ...
The Prostar XL 10 is a suture mediated closure system. It can be used with 10F sheath. It has two 3-0 braided polyester sutures and also has the safety of guidewire....
Medicine Products: